TRIPLE-DRUG THERAPY VERSUS SELECT USE OF DUAL NUCLEOSIDE ANALOGS AS FRONT-LINE ANTIRETROVIRAL TREATMENT - A COST COMPARISON

Authors
Citation
Rs. Dir et Sc. Zell, TRIPLE-DRUG THERAPY VERSUS SELECT USE OF DUAL NUCLEOSIDE ANALOGS AS FRONT-LINE ANTIRETROVIRAL TREATMENT - A COST COMPARISON, Journal of investigative medicine, 46(1), 1998, pp. 100-100
Citations number
NO
Categorie Soggetti
Medicine, Research & Experimental","Medicine, General & Internal
ISSN journal
10815589
Volume
46
Issue
1
Year of publication
1998
Pages
100 - 100
Database
ISI
SICI code
1081-5589(1998)46:1<100:TTVSUO>2.0.ZU;2-U